Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04107103 · COMPLETED
Trial details
- NCT number
- NCT04107103
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-19
- Primary completion
- 2023-04-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.